KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Moderna (MRNA) Shares Repurchased (2021 - 2023)

Moderna (MRNA) has disclosed Shares Repurchased for 3 consecutive years, with -$1.0 million as the latest value for Q3 2023.

  • On a quarterly basis, Shares Repurchased fell 100.1% to -$1.0 million in Q3 2023 year-over-year; TTM through Jun 2024 was -$1.0 million, a 100.04% decrease, with the full-year FY2025 number at $2.0 million, changed N/A from a year prior.
  • Shares Repurchased was -$1.0 million for Q3 2023 at Moderna, down from $628.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $1.3 billion in Q2 2022 to a low of -$1.0 million in Q3 2023.
  • A 3-year average of $667.4 million and a median of $625.5 million in 2022 define the central range for Shares Repurchased.
  • Biggest YoY gain for Shares Repurchased was 15.57% in 2023; the steepest drop was 100.1% in 2023.
  • Moderna's Shares Repurchased stood at $857.0 million in 2021, then tumbled by 53.09% to $402.0 million in 2022, then tumbled by 100.25% to -$1.0 million in 2023.
  • Per Business Quant, the three most recent readings for MRNA's Shares Repurchased are -$1.0 million (Q3 2023), $628.0 million (Q2 2023), and $526.0 million (Q1 2023).